ExodusPoint Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,049
| Closed | -$24K | – | 1465 |
|
|
2024
Q1 | $24K | Buy |
+11,049
| New | +$24K | ﹤0.01% | 1316 |
|
|
2022
Q3 | – | Sell |
-162,990
| Closed | -$298K | – | 1902 |
|
|
2022
Q2 | $298K | Buy |
162,990
+135,810
| +500% | +$248K | ﹤0.01% | 1491 |
|
|
2022
Q1 | $73K | Sell |
27,180
-80,185
| -75% | -$215K | ﹤0.01% | 1970 |
|
|
2021
Q4 | $465K | Buy |
107,365
+69,873
| +186% | +$303K | ﹤0.01% | 1424 |
|
|
2021
Q3 | $191K | Buy |
37,492
+11,268
| +43% | +$57.4K | ﹤0.01% | 1747 |
|
|
2021
Q2 | $166K | Buy |
+26,224
| New | +$166K | ﹤0.01% | 1960 |
|
|
2021
Q1 | – | Sell |
-41,728
| Closed | -$273K | – | 2123 |
|
|
2020
Q4 | $273K | Buy |
41,728
+12,365
| +42% | +$80.9K | ﹤0.01% | 1513 |
|
|
2020
Q3 | $195K | Buy |
29,363
+12,893
| +78% | +$85.6K | ﹤0.01% | 1429 |
|
|
2020
Q2 | $137K | Buy |
+16,470
| New | +$137K | ﹤0.01% | 1566 |
|
|
2020
Q1 | – | Sell |
-33,879
| Closed | -$282K | – | 1121 |
|
|
2019
Q4 | $282K | Buy |
33,879
+4,245
| +14% | +$35.3K | 0.01% | 1116 |
|
|
2019
Q3 | $219K | Buy |
29,634
+8,904
| +43% | +$65.8K | 0.01% | 1048 |
|
|
2019
Q2 | $233K | Buy |
+20,730
| New | +$233K | 0.01% | 804 |
|